Page Content
to Navigation
“Living up to Improved Performance” - The role of international projects
Britta Zander
Eupha 22.11.2014
Provision of health services: Trends and patterns in Europe (EU 28 + Iceland, Norway and Switzerland)
W. Quentin, J. Cylus, A. Geissler, A. Maresso, S. Merkur, G. Pastorino, A. Sagan
Glasgow 21.11.2014
Hospital payment and Diagnosis - Related Groups in Germany - Boone or Bane?
Alexander Geissler, Dr.
Dubrovnik 14.11.2014
DRGs: Are hospitals paid for what they do – or do they do for what they are paid? And why patients should care about it
Reinhard Busse, Prof. Dr. med. MPH FFPH
Doha 21.10.2014
Medical devices:a taxonomy suitable for HTA
Reinhard Busse, Prof. Dr. med. MPH FFPH
Warsaw, 26.09.2014
Medical devices:differences vs. other technologies, especially pharmaceuticals
Reinhard Busse, Prof. Dr. med. MPH FFPH
Warsaw, 26.09.2014
Inequalities in Health and Health Care
Martin Siegel, Dr.
Dresden 22.09.2014
Exploringbarriers and dilemmas for the adoption of cost containment strategies in the economic, institutional and political environment
Reinhard Busse, Prof. Dr. med. MPH FFPH
Brussels 17.09.2014
The German health system: basics and some comparisons with other countries
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 16.09.2014
From a conservative to a liberal welfare state: decomposing changes in income-related health inequalities in Germany, 1994-2011
Martin Siegel, Dr.
Dublin 16.07.2014
Towards a taxonomy ofmedical devices in the logic of HTA and economic evaluationsrather than marketing authorization
Reinhard Busse, Prof. Dr. med. MPH FFPH
Dublin 15.07.2014
A taxonomy of medical devices in the logic of HTA
Dimitra Panteli
Washington 16.06.2014
Equity considerations among HTA agencies –current practice and ways forward
Dimitra Panteli
Washington 16.06.2014
The role of dissemination bias in pharmaceutical coverage decisions: an analysis of practices in European countries
Dimitra Panteli
Washington 16.06.2014
The process of evidence-based decision-making for the reimbursement and pricing of pharmaceuticals in Europe: mapping approaches in 36 countries
Dimitra Panteli
Washington 16.06.2014
Intoduction to the healthcare ecosystem and cost factors
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 05.05.2014
The Health Systems and Policy Monitor (HSPM)
Wilm Quentin, Dr. med MSc HPPF
Brazzaville 29.04.2014
The European Observatory on Health Systems and Policies
Wilm Quentin, Dr. med MSc HPPF
Brazzaville 28.04.2014
Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview (II)
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014
Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview (I)
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014
Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 14.04.2014
Health care reform and pharmaceutical policies in Germany
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014
Addressing emerging patient needs:from free choice to integrated care
Reinhard Busse, Prof. Dr. med. MPH FFPH
Brussels 21.03.2014
Hospital payment and DRGs in Germany: The G-DRG system
Wilm Quentin, Dr. med MSc HPPF
Warsaw 18.03.2014
The effect of continuity of ambulatory care on hospitalizations in patients with heart failure
Verena Vogt
Munich 17.03.2014
The Latvian Health System
Uldis Mittenbergs & Wilm Quentin
Brussels 07.03.2014
Regulation and governance of providers (especially hospitals)
Reinhard Busse, Prof. Dr. med. MPH FFPH
Jerusalem 04.03.2014
DRGs in Europe: towards transparency, efficiency, and quality of hospital care?
Reinhard Busse, Prof. Dr. med. MPH FFPH
Jerusalem 04.03.2014
Implementing competitive UHI: benefit basket, pooling, risk-related allocation and other important considerations
Reinhard Busse, Prof. Dr. med. MPH FFPH
Dublin 23.01.2014
The financing function: Raising, pooling and allocating resources
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014
Differences in health care structure and incentives – do they worsen or reduce health inequalities?(… and a framework to examine access to health care …)
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014
Health system reforms in times of crisis: EU countries
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014